A synthetic peptide for use as a blocking control in assays to test for specificity of CDC5 L antibody, Alternative Names: CDC5L control peptide, CDC5L antibody Blocking Peptide, Anti-CDC5L Blocking Peptide, Cdc5 Cell Division Cycle 5-Like Blocking Peptide, CEF1 Blocking Peptide, KIAA0432 Blocking Peptide, PCDC5RP Blocking Peptide, dJ319D22.1 Blocking Peptide, hCDC5 Blocking Peptide, CDC5, CDC-5, CDC 5, CDC-5 Blocking Peptide, CDC 5 Blocking Peptide
CDC5L
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CDC5L
(CDC5 Cell Division Cycle 5-Like (S. Pombe) (CDC5L))
Hintergrund
CDC5L shares a significant similarity with Schizosaccharomyces pombe cdc5 gene product, which is a cell cycle regulator important for G2/M transition. CDC5L has been demonstrated to act as a positive regulator of cell cycle G2/M progression. It was also found to be an essential component of a non-snRNA spliceosome, which contains at least five additional protein factors and is required for the second catalytic step of pre-mRNA splicing.